Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression.

Bladder cancer (Amsterdam, Netherlands)

Godoy G, Gakis G, Smith CL, Fahmy O.
PMID: 27376135
Bladder Cancer. 2016 Apr 27;2(2):127-137. doi: 10.3233/BLC-160052.

Epidemiologic studies have long demonstrated clear differences in incidence and progression of bladder cancer between genders suggesting that the mechanisms of development and progression in these tumors have a strong association with steroid hormonal pathways. Such observations led to...

Cite
Godoy G, Gakis G, Smith CL, et al. Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression. Bladder Cancer. 2016;2(2):127-137doi: 10.3233/BLC-160052.
Godoy, G., Gakis, G., Smith, C. L., & Fahmy, O. (2016). Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression. Bladder cancer (Amsterdam, Netherlands), 2(2), 127-137. https://doi.org/10.3233/BLC-160052
Godoy, Guilherme, et al. "Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression." Bladder cancer (Amsterdam, Netherlands) vol. 2,2 (2016): 127-137. doi: https://doi.org/10.3233/BLC-160052
Godoy G, Gakis G, Smith CL, Fahmy O. Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression. Bladder Cancer. 2016 Apr 27;2(2):127-137. doi: 10.3233/BLC-160052. PMID: 27376135; PMCID: PMC4927898.
Copy Download .nbib Format: NLM
Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Translational oncology

George SK, Tovar-Sepulveda V, Shen SS, Jian W, Zhang Y, Hilsenbeck SG, Lerner SP, Smith CL.
PMID: 23730403
Transl Oncol. 2013 Jun 01;6(3):244-55. doi: 10.1593/tlo.13247. Print 2013 Jun.

Bladder cancer is the fifth most frequent tumor in men and ninth in women in the United States. Due to a high likelihood of recurrence, effective chemoprevention is a significant unmet need. Estrogen receptors (ERs), primarily ERĪ², are expressed...

Cite
George SK, Tovar-Sepulveda V, Shen SS, et al. Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. Transl Oncol. 2013;6(3):244-55doi: 10.1593/tlo.13247.
George, S. K., Tovar-Sepulveda, V., Shen, S. S., Jian, W., Zhang, Y., Hilsenbeck, S. G., Lerner, S. P., & Smith, C. L. (2013). Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. Translational oncology, 6(3), 244-55. https://doi.org/10.1593/tlo.13247
George, Suraj Konnath, et al. "Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen." Translational oncology vol. 6,3 (2013): 244-55. doi: https://doi.org/10.1593/tlo.13247
George SK, Tovar-Sepulveda V, Shen SS, Jian W, Zhang Y, Hilsenbeck SG, Lerner SP, Smith CL. Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen. Transl Oncol. 2013 Jun 01;6(3):244-55. doi: 10.1593/tlo.13247. Print 2013 Jun. PMID: 23730403; PMCID: PMC3660792.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries